Arevipharma offers a broad range of synthetic, generic active ingredients in various volume, indication and substance classes. All active ingredients are produced at the site in Radebeul under cGMP conditions and are already registered in many global pharmaceutical markets. In consultation with our customers, we also regularly tackle registration projects in countries that are additionally required for their marketing strategy, at short notice and reliably.

Narcotics represent an important part of our portfolio of active ingredients. Arevipharma can handle all classes of these active ingredients without any restrictions on their volumes. This makes us one of the largest producers of narcotics in the world.


Product Indication Regulatory Documentation
Amfepramon Hydrochloride Appetite Depressant US-DMF, ASMF
Buprenorphine Analgesic CEP, US-DMF, ASMF
Buprenorphine Hydrochloride Analgesic CEP, US-DMF, ASMF
Fentanyl Analgesic CEP, US-DMF, ASMF
Fentanyl Citrate Analgesic CEP, ASMF
Remifentanil Hydrochloride Analgesic CEP, ASMF
Tilidine Hydrochloride Hemihydrate Analgesic CEP, ASMF
Product Indication Regulatory Documentation
Amiodarone Hydrochloride Antiarrhythmic CEP, ASMF
Arketamine Hydrochloride Antidepressant ASMF
Bisoprolol Fumarate Antihypertonic, beta block CEP, US-DMF, J-DMF, ASMF
Cafedrine Hydrochloride Cardiac Stimulant ASMF
Cannabidiol Anti-epileptic, Various ASMF
Carbamazepine Antiepileptic, Anticonvulsant CEP, ASMF
Cetirizine Dihydrochloride Antihistaminic CEP, ASMF
Dimethylfumarate Psoriasis, Multiple Sclerosis US-DMF, ASMF
Doxapram Hydrochloride Analeptic CEP, US-DMF, J-DMF
Ebastine Antihistaminic CEP, ASMF
Esketamine Hydrochloride Analgesic, Anti-depressant CEP, US-DMF, ASMF
Ketamine Hydrochloride Analgesic CEP, US-DMF, ASMF
Phenprocoumon Anticoagulant ASMF
Phytosterol Urological diseases ASMF
Pyridostigmine Bromide Parasympathomimetic CEP, C-DMF, ASMF
Sotalol HCl Antiarrhythmic, Beta blocker CEP, ASMF
Sultiame Antiepileptic, Anticonvulsant ASMF
Theodrenaline Cardiac Stimulant ASMF
Torasemide Diuretic CEP, ASMF, J-DMF
Product Indication Status
Alpelsib Anticancer Under Evaluation
Diroximel Fumarate Multiple Sclerosis Under Evaluation
Gilteritinib Anticancer Under Evaluation
(Hydroxy-/)Norketamine Antidepressant Laboratory Assessment
Oliceridine Analgesic Under Evaluation
Ribociclib Anticancer Under Evaluation
Rivastigmine (Tartrate) Alzheimer’s Disease Validation Q2 2024
Sufentanil Analgesic Laboratory Assessment
Tirbanibulin Actinic keratosis Under Evaluation
Tivozanib Anticancer Laboratory Assessment
Vismodegib Anticancer Laboratory Assessment

We are happy to advise you

We are looking forward to your inquiry
regarding our active ingredient portfolio or your CDMO project.